Latest News

Mhome Group Constructs 90sqm Prefabricated Display Home in Just 33 Hours

WUHAN, China, Dec. 21, 2020 /PRNewswire/ -- Mhome Group (000667.SZ), a leading Chinese real estate developer headquartered inWuhan, has once again made a breakthrough in the prefabricated construction industry by completing the main structure of its first prefabricated display home in just 33 hou...

2020-12-21 15:21 3544

OneSmart Restructures Investment Portfolio of Small-Class Business to Focus on Premium Personalized Tutoring Business

SHANGHAI, Dec. 21, 2020 /PRNewswire/ -- OneSmart International Education Group Limited (NYSE: ONE) ("OneSmart" or the "Company"), the leading premium K-12 after-school education services provider inChina, today announced that it has entered into certain agreements to establish a sizable and stron...

2020-12-21 14:00 10177

Tencent Music Partners with Norwegian Embassy in China on Collaborative Music Album

SHENZHEN, China, Dec. 20, 2020 /PRNewswire/ -- Tencent Music Entertainment Group (Tencent Music or TME, NYSE: TME), the leading online music entertainment platform inChina, has partnered with the Royal Norwegian Embassy in Beijing to launch a collaborative cross-border music album,Norwegian Speci...

2020-12-21 11:27 4338

AInnovation Completes Series C Financing Led by CICC ALPHA and Enters Unicorn Club

BEIJING, Dec. 20, 2020 /PRNewswire/ -- AInnovation recently completed Series C financing, entering the unicorn club. This financing round was led by CICC ALPHA, followed by Guohe Capital and Riverhead Capital. The previous shareholder Huaxing Growth Capital also continued to increase its posit...

2020-12-21 10:43 1637

ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment

Followed by Russia, Indonesia, and Korea, the second phase of the COVID-19 clinical trial was approved inItaly on Friday, December 18, 2020. CHUNCHEON, South Korea, Dec. 20, 2020 /PRNewswire/ -- The broad spectrum antiviral therapeutic, 'hzVSF-v13(humanized Virus Suppressing Factor)' being devel...

2020-12-21 10:43 1436

Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China

SUZHOU, China and PARIS, Dec. 20, 2020 /PRNewswire/ -- Peijia Medical Ltd (HK Stock Code: 09996) and HighLife SAS, aParis-based medical device company, focused on the development of a unique transeptal mitral valve replacement ("TMVR") system to treat patients suffering from mitral regurgitation,...

2020-12-21 10:00 4152

Week's Top Stories